Visual acuity outcomes among sham vs no-treatment controls from randomized trials

Archives of Ophthalmology

Volumn 127, Issue 6, 2009, Pages 725-731

  Hawkins, Barbara S ^a,b   Bressler, Neil M ^a   Reynolds, Sandra M ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESEARCH ETHICS; SHAM PROCEDURE; VISUAL ACUITY;

CHOROIDAL NEOVASCULARIZATION; HUMANS; LASER COAGULATION; MACULAR DEGENERATION; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLACEBOS; PORPHYRINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 66949111441     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.101     Document Type: Article

References (30)

1. Kaptchuk TJ. Powerful placebo: the dark side of the randomised controlled trial. Lancet. 1998;351(9117):1722-1725. (Pubitemid 28254542)
2. Vickers AJ, de Craen AJM. Why use placebos in clinical trials? a narrative review of the methodological literature. J Clin Epidemiol. 2000;53(2):157-161. (Pubitemid 30151220)
3. Robertson DM, Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol. 1983;95(4):457-466.
4. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351(27):2805-2816.
5. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-1431.
6. Radiation Therapy for Age-Related Macular Degeneration (RAD) Study Group. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Ophthalmology. 1999;106(12):2239-2247.
7. Marcus DM, Camp MW, Sheils WC, et al. Sham radiation in clinical trials assessing radiotherapy for exudative age-related macular degeneration. Retina. 1999;19(6):525-530. (Pubitemid 30387487)
8. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials: TAP report 1 [published correction appears in Arch Ophthalmol. 2000;118(4):488]. Arch Ophthalmol. 1999;117(10):1329-1345.
9. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials: TAP report 2. Arch Ophthalmol. 2001;119(2):198-207.
10. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: twoyear results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization: Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol. 2001;131(5):541-560.
11. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR; Vitrase for Vitreous Hemorrhage Study Groups. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol. 2005;140(4):573-584. (Pubitemid 41455296)
12. McDonald CJ, Mazzuca SA, McCabe GP Jr. How much of the placebo "effect" is really statistical regression? Stat Med. 1983;2(4):417-427.
13. Heckerling PS. Ethical aspects in trials of implantable medical devices. JAMA. 2003;290(12):1579.
14. Horng S, Miller FG. Is placebo surgery unethical? N Engl J Med. 2002;347(2):137-139. (Pubitemid 34753486)
15. London AJ, Kadane JB. Sham surgery and genuine standards of care: can the two be reconciled? Am J Bioeth. 2003;3(4):61-64.
16. Angelos P. Sham surgery in research: a surgeon's view. Am J Bioeth. 2003;3(4):65-66.
17. Convergence Insufficiency Treatment Trial (CITT) Study Group. The Convergence Insufficiency Treatment Trial: design, methods, and baseline data. Ophthalmic Epidemiol. 2008;15(1):24-36. (Pubitemid 351311496)
18. Brown DM, Kaiser PK, Michels M, et al; ANCHOR Study Group. Ranibizumab vs verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432-1444. (Pubitemid 44511558)
19. Age-Related Eye Disease Study 2 (AREDS2). http://www.clinicaltrials.gov/ ct2 /show/NCT00345176. Accessed September 12, 2008.
20. Blades KJ, Patel S, Aidoo KE. Oral antioxidant therapy for marginal dry eye. Eur J Clin Nutr. 2001;55(7):589-597. (Pubitemid 32591236)
21. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions [update of Cochrane Database Syst Rev. 2003;(1):CD003974]. Cochrane Database Syst Rev. 2004;(2):CD003974. doi:10.1002/14651858.CD003974. pub2.
22. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? an analysis of clinical trials comparing placebo with no treatment [published correction appears in N Engl J Med. 2001;345(4):304]. N Engl J Med. 2001;344(21):1594-1602.
23. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109(9):1220-1231.
24. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109(9):1232-1241.
25. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol. 1993;111(9):1200-1209. (Pubitemid 23268780)
26. Submacular Surgery Trials (SST) Research Group. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology. 2004;111(11):1967-1980. (Pubitemid 39446714)
27. Tukey JW. Exploratory Data Analysis. Reading, MA: Addison-Wesley Publishing Co; 1977:39-41.
28. Altman DG. Practical Statistics for Medical Research. London, England: Chapman & Hall; 1991:203-205.
29. Altman DG. Practical Statistics for Medical Research. London, England: Chapman & Hall; 1991:258-259.
30. Marcus DM, Peskin E; AMDRT Research Group. The Age-Related Macular Degeneration Radiotherapy Trial (AMDRT): one year results from a pilot study. Am J Ophthalmol. 2004;138(5):818-828. (Pubitemid 39452930)